Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Simon, Christopher
Haemonetics | 8-K: Current report
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.65%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Neuberger Berman Group LLC(6.96%),Neuberger Berman Investment Advisers LLC(6.89%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital Research Global Investors(12.9%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(6.44%),Wellington Group Holdings LLP(6.44%), etc.
Haemonetics | 10-Q: Quarterly report
Haemonetics | 8-K: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(11.9%)
Haemonetics | 8-K: Current report
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Galvin Roy
Haemonetics | 10-Q: Q2 2024 Earnings Report
Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Basil Michelle L
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
Haemonetics | 8-K/A: Current report (Amendment)
Haemonetics | 8-K: Current report
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Lingamneni Anila
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
No Data